Literature DB >> 9915521

Occult breast carcinoma presenting as an axillary mass.

C R Scoggins1, J V Vitola, M P Sandler, J B Atkinson, M Frexes-Steed.   

Abstract

Breast carcinoma presents rarely (<5% of cases) as an axillary mass without an obvious primary tumor. The value of mammography in detecting an occult breast carcinoma is low, with a sensitivity of 29 per cent and specificity of 73 per cent. MRI and positron emission tomography (PET) are potentially more sensitive in this setting. We present a case recently seen at the Vanderbilt University Hospital, a 63-year-old woman with a 2-cm painless mass in the right axilla. Mammography was negative, and fine needle aspiration revealed atypical cells suspicious for malignancy. An excisional biopsy of the right axillary lymph node revealed metastatic adenocarcinoma, most likely breast primary. A PET showed increased uptake of 18-fluorodeoxyglucose and 99m Technetium in the right axilla and the right lateral breast. The patient underwent right modified radical mastectomy. The final pathological report revealed a 0.9-cm primary tumor in the upper inner quadrant of the breast and 1 of 41 nodes positive for tumor. This case confirms that mammography has low sensitivity in identifying the primary tumor in occult breast carcinoma and illustrates the usefulness of PET in identifying the primary tumor. We advocate an aggressive approach to evaluation of the breast in women presenting with metastatic adenocarcinoma in the axillary nodes. This evaluation should include clinical examination and mammography in all cases, and PET and MRI in selected cases. PET and MRI may be particularly useful when considering a breast-conserving surgical procedure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915521

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Hypermetabolic Axillary Mass on (18)F FDG PET/CT: Breast Cancer Arising from Accessory Breast Tissue.

Authors:  Ji Sun Park; Ah Young Lee; Sang Gyun Bae; Seok Mo Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-09-30

2.  Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy.

Authors:  Katrien Schelfout; E Kersschot; M Van Goethem; L Thienpont; J Van den Haute; A Roelstraete; A De Schepper
Journal:  Eur Radiol       Date:  2002-11-19       Impact factor: 5.315

3.  Accuracy of (99m)Tc-sestamibi scintimammography for breast cancer diagnosis.

Authors:  Sonia Marta Moriguchi; Laurival Antônio DE Luca; Beatriz Lotufo Griva; Kátia Hiromoto Koga; Eduardo Tinois DA Silva; Heloisa DE Luca Vespoli; Gilberto Uemura
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

4.  A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China.

Authors:  Jing Li; Bao-Ning Zhang; Jin-Hu Fan; Yi Pang; Pin Zhang; Shu-Lian Wang; Shan Zheng; Bin Zhang; Hong-Jian Yang; Xiao-Ming Xie; Zhong-Hua Tang; Hui Li; Jia-Yuan Li; Jian-Jun He; You-Lin Qiao
Journal:  BMC Cancer       Date:  2011-08-22       Impact factor: 4.430

5.  A case of breast cancer in the axillary tail of Spence - enhanced magnetic resonance imaging and positron emission tomography for diagnostic differentiation and preoperative treatment decision.

Authors:  Mai Okubo; Keiichiro Tada; Takayoshi Niwa; Kotoe Nishioka; Eiichi Tsuji; Toshihisa Ogawa; Yasuyuki Seto
Journal:  World J Surg Oncol       Date:  2013-09-03       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.